Burning Rock Biotech (BNR) Shares Outstanding (2021 - 2023)

Burning Rock Biotech has reported Shares Outstanding over the past 3 years, most recently at $14.2 million for Q4 2023.

  • Quarterly results put Shares Outstanding at $14.2 million for Q4 2023, down 1.42% from a year ago — trailing twelve months through Dec 2023 was $14.2 million (down 1.42% YoY), and the annual figure for FY2023 was $14.2 million, down 6.93%.
  • Shares Outstanding for Q4 2023 was $14.2 million at Burning Rock Biotech, down from $14.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding for BNR hit a ceiling of $16.4 million in Q4 2021 and a floor of $14.2 million in Q4 2023.
  • Median Shares Outstanding over the past 3 years was $14.4 million (2022), compared with a mean of $15.0 million.
  • Biggest five-year swings in Shares Outstanding: dropped 12.21% in 2022 and later dropped 1.42% in 2023.
  • Burning Rock Biotech's Shares Outstanding stood at $16.4 million in 2021, then decreased by 12.21% to $14.4 million in 2022, then decreased by 1.42% to $14.2 million in 2023.
  • The last three reported values for Shares Outstanding were $14.2 million (Q4 2023), $14.4 million (Q4 2022), and $16.4 million (Q4 2021) per Business Quant data.